Skip to main content
Erschienen in: Clinical Rheumatology 2/2022

08.09.2021 | Original Article

Association of interleukin-6 promoter polymorphism with rheumatoid arthritis: a meta-analysis with trial sequential analysis

verfasst von: Ming Shao, Huimin Xie, Hui Yang, Wei Xu, Yuting Chen, Xing Gao, Shiyang Guan, Shengqian Xu, Zongwen Shuai, Faming Pan

Erschienen in: Clinical Rheumatology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The association of interleukin-6 (IL-6) -174G/C (rs1800795) and IL-6 -572G/C (rs1800796) single-nucleotide polymorphism (SNP) with the risk of acquiring rheumatoid arthritis (RA) was inconsistent among previous studies. This paper aims to investigate the association between IL-6 promoter polymorphism with RA in different ethnics.

Methods

Relevant studies were searched using Medline and Google Search engines; STATA software was used to perform the meta-analysis. Pooled odds ratios (OR) were calculated to estimate the potential genetic associations. Subgroup analysis and sensitivity analysis were applied to explore the sources of heterogeneity. Lastly, we used TSA (trial sequential analysis) software to verify the reliability of meta-analysis results.

Results

A total of 18 studies were included, involving 8116 subjects (3820 RA patients and 4296 controls). We found a tendency to associate RA with the IL-6 -174G/C allele in Asians (C vs G: OR = 4.56, 95% CI = 1.85–11.23; P < 0.001); with IL-6 -572G/C genotype or allele frequencies, there was no statistical differences between RA patients and controls (P > 0.05). TSA results indicate that the current meta-analysis can draw conclusions.

Conclusions

IL-6-174G/C gene polymorphism were associated with increased risk of RA in Asians, but not in Caucasians. There was no association between IL-6 -572G/C gene polymorphism and the risk of RA.
Key Points
• Although the association between interleukin-6 (IL-6) promoter polymorphism and rheumatic arthritis (RA) has been discussed in the previous meta-analysis, their conclusions are inconsistent.
• In this study, trial sequential analysis (TSA) was introduced into the meta-analysis, and the following two important conclusions were confirmed: (1) IL-6-174G/C gene polymorphism was associated with increased risk of RA in Asians, but not in Caucasians. (2) There was no association between IL-6 -572G/C gene polymorphism and the risk of RA.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219CrossRef McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219CrossRef
2.
Zurück zum Zitat Jančić I, Arsenović-Ranin N, Sefik-Bukilica M, Zivojinović S, Damjanov N, Spasovski V, Srzentić S, Stanković B, Pavlović S (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33(6):1481–1486CrossRef Jančić I, Arsenović-Ranin N, Sefik-Bukilica M, Zivojinović S, Damjanov N, Spasovski V, Srzentić S, Stanković B, Pavlović S (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33(6):1481–1486CrossRef
3.
Zurück zum Zitat Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440CrossRef Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440CrossRef
4.
Zurück zum Zitat Miossec P (2004) An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16(3):218–222CrossRef Miossec P (2004) An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16(3):218–222CrossRef
5.
Zurück zum Zitat Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M et al (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18(11):1797–1801CrossRef Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M et al (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18(11):1797–1801CrossRef
6.
Zurück zum Zitat Nishimoto N, Kishimoto T (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2(11):619–626CrossRef Nishimoto N, Kishimoto T (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2(11):619–626CrossRef
7.
Zurück zum Zitat Ji YF, Jiang X, Li W, Ge X (2019) Impact of interleukin-6 gene polymorphisms and its interaction with obesity on osteoporosis risk in Chinese postmenopausal women. Environ Health Prev Med 24(1):48CrossRef Ji YF, Jiang X, Li W, Ge X (2019) Impact of interleukin-6 gene polymorphisms and its interaction with obesity on osteoporosis risk in Chinese postmenopausal women. Environ Health Prev Med 24(1):48CrossRef
8.
Zurück zum Zitat You CG, Li XJ, Li YM, Wang LP, Li FF, Guo XL, Gao LN (2013) Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population. Cytokine 61(1):133–138CrossRef You CG, Li XJ, Li YM, Wang LP, Li FF, Guo XL, Gao LN (2013) Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population. Cytokine 61(1):133–138CrossRef
9.
Zurück zum Zitat Zavaleta-Muñiz SA, Martín-Márquez BT, Gonzalez-Lopez L, Gonzalez-Montoya NG, Díaz-Toscano ML, Ponce-Guarneros JM, Ruiz-Padilla AJ, Vázquez-Del Mercado M, Maldonado-González M, Fafutis-Morris M, Flores-Martínez SE, Martínez-García EA, Gamez-Nava JI (2013) The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study. Clin Dev Immunol. 2013:959084CrossRef Zavaleta-Muñiz SA, Martín-Márquez BT, Gonzalez-Lopez L, Gonzalez-Montoya NG, Díaz-Toscano ML, Ponce-Guarneros JM, Ruiz-Padilla AJ, Vázquez-Del Mercado M, Maldonado-González M, Fafutis-Morris M, Flores-Martínez SE, Martínez-García EA, Gamez-Nava JI (2013) The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study. Clin Dev Immunol. 2013:959084CrossRef
10.
Zurück zum Zitat Wielińska J, Dratwa M, Świerkot J, Korman L, Iwaszko M, Wysoczańska B, Bogunia-Kubik K (2018) Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA 92(Suppl 2):38–41CrossRef Wielińska J, Dratwa M, Świerkot J, Korman L, Iwaszko M, Wysoczańska B, Bogunia-Kubik K (2018) Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA 92(Suppl 2):38–41CrossRef
11.
Zurück zum Zitat Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H (2012) Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int 32(7):2199–2201CrossRef Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H (2012) Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int 32(7):2199–2201CrossRef
12.
Zurück zum Zitat Shafia S, Dilafroze, Sofi FA, Rasool R, Javeed S, Shah ZA (2014) Rheumatoid arthritis and genetic variations in cytokine genes: a population-based study in Kashmir Valley. Immunol Invest. 43(4):349–59CrossRef Shafia S, Dilafroze, Sofi FA, Rasool R, Javeed S, Shah ZA (2014) Rheumatoid arthritis and genetic variations in cytokine genes: a population-based study in Kashmir Valley. Immunol Invest. 43(4):349–59CrossRef
13.
Zurück zum Zitat Dar SA, Haque S, Mandal RK, Singh T, Wahid M, Jawed A, Panda AK, Akhter N, Lohani M, Areeshi MY, Rai G, Datt S, Bhattacharya SN, Ramachandran VG, Das S (2017) Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: a case-control study and meta-analysis. Autoimmunity 50(3):158–169CrossRef Dar SA, Haque S, Mandal RK, Singh T, Wahid M, Jawed A, Panda AK, Akhter N, Lohani M, Areeshi MY, Rai G, Datt S, Bhattacharya SN, Ramachandran VG, Das S (2017) Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: a case-control study and meta-analysis. Autoimmunity 50(3):158–169CrossRef
14.
Zurück zum Zitat Amr K, El-Awady R, Raslan H (2016) Assessment of the -174G/C (rs1800795) and -572G/C (rs1800796) Interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis. Open Access Maced J Med Sci 4(4):574–577CrossRef Amr K, El-Awady R, Raslan H (2016) Assessment of the -174G/C (rs1800795) and -572G/C (rs1800796) Interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis. Open Access Maced J Med Sci 4(4):574–577CrossRef
15.
Zurück zum Zitat Emonts M, Hazes MJ, Houwing-Duistermaat JJ, van der Gaast-de Jongh CE, de Vogel L, Han HK, Wouters JM, Laman JD, Dolhain RJ (2011) Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 12:36CrossRef Emonts M, Hazes MJ, Houwing-Duistermaat JJ, van der Gaast-de Jongh CE, de Vogel L, Han HK, Wouters JM, Laman JD, Dolhain RJ (2011) Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 12:36CrossRef
16.
Zurück zum Zitat Panoulas VF, Douglas KM, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kitas GD (2009) Transforming growth factor-beta1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology (Oxford) 48(2):113–118CrossRef Panoulas VF, Douglas KM, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kitas GD (2009) Transforming growth factor-beta1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology (Oxford) 48(2):113–118CrossRef
17.
Zurück zum Zitat Trajkov D, Mishevska-Perchinkova S, Karadzova-Stojanoska A, Petlichkovski A, Strezova A, Spiroski M (2009) Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol 28(11):1291–1300CrossRef Trajkov D, Mishevska-Perchinkova S, Karadzova-Stojanoska A, Petlichkovski A, Strezova A, Spiroski M (2009) Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol 28(11):1291–1300CrossRef
18.
Zurück zum Zitat Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J, Martin J, Gonzalez-Gay MA (2009) Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 27(6):964–970PubMed Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J, Martin J, Gonzalez-Gay MA (2009) Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 27(6):964–970PubMed
19.
Zurück zum Zitat Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34(2):109–113CrossRef Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34(2):109–113CrossRef
20.
Zurück zum Zitat Huang XZ, Zhuang JH, Ren YG, Zhou LJ, Zhou Q (2007) Association of interleukin-6 and interleukin-18 gene polymorphism with rheumatoid arthritis in Guangdong Han population. Journal of Southern Medical University 11:1661–1664 Huang XZ, Zhuang JH, Ren YG, Zhou LJ, Zhou Q (2007) Association of interleukin-6 and interleukin-18 gene polymorphism with rheumatoid arthritis in Guangdong Han population. Journal of Southern Medical University 11:1661–1664
21.
Zurück zum Zitat Li YH, Sun W, SQ Wang, Yang SC (2009) Study on interleukin-6 gene promoter polymorphism in patients with rheumatoid arthritis. Clinical Focus (19): 1715–1717 Li YH, Sun W, SQ Wang, Yang SC (2009) Study on interleukin-6 gene promoter polymorphism in patients with rheumatoid arthritis. Clinical Focus (19): 1715–1717
22.
Zurück zum Zitat Li X, Chai W, Ni M, Xu M, Lian Z, Shi L, Bai Y, Wang Y (2014) The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population. Biomed Res Int 265435 Li X, Chai W, Ni M, Xu M, Lian Z, Shi L, Bai Y, Wang Y (2014) The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population. Biomed Res Int 265435
23.
Zurück zum Zitat Li F, Xu J, Zheng J, Sokolove J, Zhu K, Zhang Y, Sun H, Evangelou E, Pan Z (2014) Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis. Sci Rep 4:5714CrossRef Li F, Xu J, Zheng J, Sokolove J, Zhu K, Zhang Y, Sun H, Evangelou E, Pan Z (2014) Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis. Sci Rep 4:5714CrossRef
24.
Zurück zum Zitat Lu YL,Yu XD (2009) Study on serum IL-6 level and gene polymorphism in patients with rheumatoid arthritis.Chinese Journal of Cellular and Molecular Immunology (08):725–726+728. Lu YL,Yu XD (2009) Study on serum IL-6 level and gene polymorphism in patients with rheumatoid arthritis.Chinese Journal of Cellular and Molecular Immunology (08):725–726+728.
25.
Zurück zum Zitat Zhuang JH, Ren YG, Huamg XZ, Ding HM, Zhou Q (2007) Study on the gene polymorphism of interleukin-6 promote rinrheumatoid arthritis patients of Chinese Han population in the region of Guangdong. Laboratory Medicine 06:697–702 Zhuang JH, Ren YG, Huamg XZ, Ding HM, Zhou Q (2007) Study on the gene polymorphism of interleukin-6 promote rinrheumatoid arthritis patients of Chinese Han population in the region of Guangdong. Laboratory Medicine 06:697–702
26.
Zurück zum Zitat Ad’hiah AH, Mahmood AS, Al-kazaz A, Mayouf K (2018) Gene expression and six single nucleotide polymorphisms of interleukin-6 in rheumatoid arthritis: a case-control study in Iraqi patients. Alexandria Journal of Medicine (54): 639–645 Ad’hiah AH, Mahmood AS, Al-kazaz A, Mayouf K (2018) Gene expression and six single nucleotide polymorphisms of interleukin-6 in rheumatoid arthritis: a case-control study in Iraqi patients. Alexandria Journal of Medicine (54): 639–645
27.
Zurück zum Zitat Hu M, Cappeleri J, Lan KK (2007) Applying the law of the iterated logarithm to control type in cumulative meta-analysis of binary outcomes. Clin Trials 4:329–340CrossRef Hu M, Cappeleri J, Lan KK (2007) Applying the law of the iterated logarithm to control type in cumulative meta-analysis of binary outcomes. Clin Trials 4:329–340CrossRef
28.
Zurück zum Zitat Borm GF, Donders AR (2009) Updating meta-analyses leads to larger type I errors than publication bias. J Clin Epidemiol 62(8):825–830CrossRef Borm GF, Donders AR (2009) Updating meta-analyses leads to larger type I errors than publication bias. J Clin Epidemiol 62(8):825–830CrossRef
29.
Zurück zum Zitat Berkey CS, Mosteller F, Lau J, Antman EM (1996) Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials 17(5):357–371CrossRef Berkey CS, Mosteller F, Lau J, Antman EM (1996) Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials 17(5):357–371CrossRef
30.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRef Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRef
31.
Zurück zum Zitat Wetterslev J, Jakobsen JC, Gluud C (2017) Trial Sequential Analysis in systematic. reviews with meta-analysis. BMC Med Res Methodol 17(1):39CrossRef Wetterslev J, Jakobsen JC, Gluud C (2017) Trial Sequential Analysis in systematic. reviews with meta-analysis. BMC Med Res Methodol 17(1):39CrossRef
33.
Zurück zum Zitat Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012 Jul) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61(7):665–671CrossRef Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012 Jul) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61(7):665–671CrossRef
34.
Zurück zum Zitat Zhang C, Jiao S, Li T, Zhao L, Chen H (2020) Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: a meta-analysis. Int J Rheum Dis. 23(1):47–54CrossRef Zhang C, Jiao S, Li T, Zhao L, Chen H (2020) Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: a meta-analysis. Int J Rheum Dis. 23(1):47–54CrossRef
35.
Zurück zum Zitat Li T, Yang L, Wang ZQ, Fu SJ (2014) Systematic evaluation on association between interleukin-6 gene polymorphism and rheumatoid arthritis susceptibility. Chongqing Medicine 43(36):4887–4890 Li T, Yang L, Wang ZQ, Fu SJ (2014) Systematic evaluation on association between interleukin-6 gene polymorphism and rheumatoid arthritis susceptibility. Chongqing Medicine 43(36):4887–4890
36.
Zurück zum Zitat Morse HR, Olomolaiye OO, Wood NA, Keen LJ, Bidwell JL (1999 Oct) Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 11(10):789–795CrossRef Morse HR, Olomolaiye OO, Wood NA, Keen LJ, Bidwell JL (1999 Oct) Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 11(10):789–795CrossRef
37.
Zurück zum Zitat Srirangan S, Choy EH (2010 Oct) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2(5):247–256CrossRef Srirangan S, Choy EH (2010 Oct) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2(5):247–256CrossRef
38.
Zurück zum Zitat Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC (2006 Jan) Interleukin 6–174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26(1):212–217CrossRef Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC (2006 Jan) Interleukin 6–174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26(1):212–217CrossRef
39.
Zurück zum Zitat Jeon JY, Kim HA, Kim SH, Park HS, Suh CH (2010 Nov) Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans. J Rheumatol 37(11):2251–2258CrossRef Jeon JY, Kim HA, Kim SH, Park HS, Suh CH (2010 Nov) Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans. J Rheumatol 37(11):2251–2258CrossRef
40.
Zurück zum Zitat Pacheco-Soto BT, Porchia LM, Lara-Vazquez WC, Torres-Rasgado E, Perez-Fuentes R, Gonzalez-Mejia ME (2020) The association between interleukin-6 promoter polymorphisms and rheumatoid arthritis by ethnicity: a meta-analysis of 33 studies. Reumatol Clin. S1699–258X(20):30079–6 Pacheco-Soto BT, Porchia LM, Lara-Vazquez WC, Torres-Rasgado E, Perez-Fuentes R, Gonzalez-Mejia ME (2020) The association between interleukin-6 promoter polymorphisms and rheumatoid arthritis by ethnicity: a meta-analysis of 33 studies. Reumatol Clin. S1699–258X(20):30079–6
41.
Zurück zum Zitat Okada Y, Wu D, Trynka G et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506(7488):376–381CrossRef Okada Y, Wu D, Trynka G et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506(7488):376–381CrossRef
42.
Zurück zum Zitat Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B (2014) Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World J Orthop 5(4):516–536CrossRef Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B (2014) Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World J Orthop 5(4):516–536CrossRef
Metadaten
Titel
Association of interleukin-6 promoter polymorphism with rheumatoid arthritis: a meta-analysis with trial sequential analysis
verfasst von
Ming Shao
Huimin Xie
Hui Yang
Wei Xu
Yuting Chen
Xing Gao
Shiyang Guan
Shengqian Xu
Zongwen Shuai
Faming Pan
Publikationsdatum
08.09.2021
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 2/2022
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05886-2

Weitere Artikel der Ausgabe 2/2022

Clinical Rheumatology 2/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.